Outcomes of Giliteritinib in R/R AML with FLT3 Positive Mutation

Speaker: Dr. Pau Montesinos

Affiliations: Attending Physician in Department of Hematology, University Hospital La Fe, Valencia, Spain

 

This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.

1
Outcomes of Giliteritinib in R/R AML with FLT3 Positive Mutation
28 minutes

Speaker: Dr. Pau Montesinos

Affiliations: Attending Physician in Department of Hematology, University Hospital La Fe, Valencia, Spain

 

This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.

Add to Wishlist
Enrolled: 2 students
Presentations: 1
Video: 28 minutes